{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:34:16Z","timestamp":1791977656317,"version":"4.4.0"},"reference-count":191,"publisher":"The Endocrine Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,4,1]]},"DOI":"10.1210\/jc.2018-00241","type":"journal-article","created":{"date-parts":[[2018,3,7]],"date-time":"2018-03-07T14:19:17Z","timestamp":1520432357000},"page":"1233-1257","source":"Crossref","is-referenced-by-count":312,"title":["Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society* Clinical Practice Guideline"],"prefix":"10.1210","volume":"103","author":[{"given":"Kathryn A","family":"Martin","sequence":"first","affiliation":[{"name":"Massachusetts General Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R Rox","family":"Anderson","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R Jeffrey","family":"Chang","sequence":"additional","affiliation":[{"name":"University of California, San Diego, La Jolla, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A","family":"Ehrmann","sequence":"additional","affiliation":[{"name":"University of Chicago, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rogerio A","family":"Lobo","sequence":"additional","affiliation":[{"name":"Columbia University, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M Hassan","family":"Murad","sequence":"additional","affiliation":[{"name":"Mayo Clinic Evidence-Based Practice Center, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel M","family":"Pugeat","sequence":"additional","affiliation":[{"name":"Hospices Civils de Lyon, Bron, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L","family":"Rosenfield","sequence":"additional","affiliation":[{"name":"University of Chicago, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2018,3,7]]},"reference":[{"issue":"7454","key":"key\n\t\t\t\t20180406135425_B1","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"Atkins","year":"2004","journal-title":"BMJ"},{"issue":"3","key":"key\n\t\t\t\t20180406135425_B2","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1210\/jc.2007-1907","article-title":"A case for clarity, consistency, and helpfulness: state-of-the-art clinical practice guidelines in endocrinology using the grading of recommendations, assessment, development, and evaluation system","volume":"93","author":"Swiglo","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"24","key":"key\n\t\t\t\t20180406135425_B3","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1056\/NEJMcp033496","article-title":"Clinical practice: hirsutism","volume":"353","author":"Rosenfield","year":"2005","journal-title":"N Engl J Med"},{"issue":"11","key":"key\n\t\t\t\t20180406135425_B4","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1210\/jcem-21-11-1440","article-title":"Clinical assessment of body hair growth in women","volume":"21","author":"Ferriman","year":"1961","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"key\n\t\t\t\t20180406135425_B5","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/0002-9378(81)90746-8","article-title":"Hirsutism: implications, etiology, and management","volume":"140","author":"Hatch","year":"1981","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"key\n\t\t\t\t20180406135425_B6","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/humupd\/dmr042","article-title":"Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society","volume":"18","author":"Escobar-Morreale","year":"2012","journal-title":"Hum Reprod Update"},{"issue":"3","key":"key\n\t\t\t\t20180406135425_B7","first-page":"370","article-title":"Clinical assessment of body hair in Colombian women: determining the cutoff score that defines hirsutism","volume":"33","author":"Rios","year":"2013","journal-title":"Biomedica"},{"issue":"3","key":"key\n\t\t\t\t20180406135425_B8","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.fertnstert.2011.06.040","article-title":"Defining hirsutism in Chinese women: a cross-sectional study","volume":"96","author":"Zhao","year":"2011","journal-title":"Fertil Steril"},{"issue":"2","key":"key\n\t\t\t\t20180406135425_B9","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ejogrb.2012.03.023","article-title":"Epidemiology of hirsutism among women of reproductive age in the community: a simplified scoring system","volume":"163","author":"Li","year":"2012","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"12","key":"key\n\t\t\t\t20180406135425_B10","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.jclinepi.2003.10.018","article-title":"Health-related quality of life in women with polycystic ovary syndrome, a self-administered questionnaire, was validated","volume":"57","author":"Guyatt","year":"2004","journal-title":"J Clin Epidemiol"},{"issue":"9","key":"key\n\t\t\t\t20180406135425_B11","doi-asserted-by":"crossref","first-page":"4116","DOI":"10.1210\/jc.2003-030424","article-title":"Metformin or antiandrogen in the treatment of hirsutism in polycystic ovary syndrome","volume":"88","author":"Harborne","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"key\n\t\t\t\t20180406135425_B12","doi-asserted-by":"crossref","first-page":"4112","DOI":"10.1210\/jc.2004-2243","article-title":"Ferriman Gallwey self-scoring I: performance assessment in women with polycystic ovary syndrome","volume":"90","author":"Wild","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"key\n\t\t\t\t20180406135425_B13","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1210\/jc.2004-2301","article-title":"Degree of facial and body terminal hair growth in unselected black and white women: toward a populational definition of hirsutism","volume":"91","author":"DeUgarte","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"key\n\t\t\t\t20180406135425_B14","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1016\/j.ajog.2004.06.064","article-title":"Ther prevelence of androgen excess among patients with minimal unwanted hair growth","volume":"191","author":"Souter","year":"2004","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"key\n\t\t\t\t20180406135425_B15","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1087-0024.2005.10106.x","article-title":"Hirsutism and the variable response of the pilosebaceous unit to androgen","volume":"10","author":"Rosenfield","year":"2005","journal-title":"J Investig Dermatol Symp Proc"},{"issue":"2","key":"key\n\t\t\t\t20180406135425_B16","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1001\/archderm.1987.01660260079018","article-title":"The relationship of mild hirsutism or acne in women to androgens","volume":"123","author":"Reingold","year":"1987","journal-title":"Arch Dermatol"},{"issue":"2","key":"key\n\t\t\t\t20180406135425_B17","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1210\/jcem-57-2-393","article-title":"Evidence for the importance of peripheral tissue events in the development of hirsutism in polycystic ovary syndrome","volume":"57","author":"Lobo","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"key\n\t\t\t\t20180406135425_B18","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1056\/NEJM199207163270304","article-title":"Detection of functional ovarian hyperandrogenism in women with androgen excess","volume":"327","author":"Ehrmann","year":"1992","journal-title":"N Engl J Med"},{"issue":"4","key":"key\n\t\t\t\t20180406135425_B19","first-page":"347","article-title":"Idiopathic hirsutism","volume":"21","author":"Azziz","year":"2000","journal-title":"Endocr Rev"},{"issue":"5","key":"key\n\t\t\t\t20180406135425_B20","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1210\/er.2015-1104","article-title":"The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited","volume":"37","author":"Rosenfield","year":"2016","journal-title":"Endocr Rev"},{"issue":"5","key":"key\n\t\t\t\t20180406135425_B21","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.fertnstert.2016.06.039","article-title":"Androgen responses to adrenocorticotropic hormone infusion among individual women with polycystic ovary syndrome","volume":"106","author":"Maas","year":"2016","journal-title":"Fertil Steril"},{"issue":"1","key":"key\n\t\t\t\t20180406135425_B22","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.fertnstert.2012.03.059","article-title":"Antim\u00fcllerian hormone levels are independently related to ovarian hyperandrogenism and polycystic ovaries","volume":"98","author":"Rosenfield","year":"2012","journal-title":"Fertil Steril"},{"issue":"1","key":"key\n\t\t\t\t20180406135425_B23","doi-asserted-by":"crossref","first-page":"8464","DOI":"10.1038\/ncomms9464","article-title":"Causal mechanisms and balancing selection inferred from genetic associations with polycystic ovary syndrome","volume":"6","author":"Day","year":"2015","journal-title":"Nat Commun"},{"issue":"1","key":"key\n\t\t\t\t20180406135425_B24","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1210\/jc.2005-1457","article-title":"Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism","volume":"91","author":"Carmina","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"key\n\t\t\t\t20180406135425_B25","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1210\/edrv.21.4.0404","article-title":"Role of hormones in pilosebaceous unit development","volume":"21","author":"Deplewski","year":"2000","journal-title":"Endocr Rev"},{"issue":"2","key":"key\n\t\t\t\t20180406135425_B26","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1210\/jc.2003-031122","article-title":"Androgen excess in women: experience with over 1000 consecutive patients","volume":"89","author":"Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"key\n\t\t\t\t20180406135425_B27","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/0002-9378(83)90998-5","article-title":"Androgen parameters and their correlation with body weight in one hundred thirty-eight women thought to have hyperandrogenism","volume":"146","author":"Wild","year":"1983","journal-title":"Am J Obstet Gynecol"},{"issue":"11","key":"key\n\t\t\t\t20180406135425_B28","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.1210\/jc.2006-1191","article-title":"Defining constant versus variable phenotypic features of women with polycystic ovary syndrome using different ethnic groups and populations","volume":"91","author":"Welt","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"key\n\t\t\t\t20180406135425_B29","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1210\/jc.2013-3399","article-title":"Hyperandrogenemia predicts metabolic phenotype in polycystic ovary syndrome: the utility of serum androstenedione","volume":"99","author":"O\u2019Reilly","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"key\n\t\t\t\t20180406135425_B30","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1093\/humrep\/dew328","article-title":"Performance of mass spectrometry steroid profiling for diagnosis of polycystic ovary syndrome","volume":"32","author":"Handelsman","year":"2017","journal-title":"Hum Reprod"},{"issue":"11","key":"key\n\t\t\t\t20180406135425_B31","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1210\/jc.2006-0284","article-title":"Circulating bioactive androgens in midlife women","volume":"91","author":"Chen","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"key\n\t\t\t\t20180406135425_B32","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1210\/jc.2012-2912","article-title":"Liquid chromatography-tandem mass spectrometry analysis of human adrenal vein 19-carbon steroids before and after ACTH stimulation","volume":"98","author":"Rege","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"key\n\t\t\t\t20180406135425_B33","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1093\/humupd\/dmx014","article-title":"Non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency revisited: an update with a special focus on adolescent and adult women","volume":"23","author":"Carmina","year":"2017","journal-title":"Hum Reprod Update"},{"issue":"6","key":"key\n\t\t\t\t20180406135425_B34","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1210\/jc.2002-020922","article-title":"The value of the low-dose dexamethasone suppression test in the differential diagnosis of hyperandrogenism in women","volume":"88","author":"Kaltsas","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20180406135425_B35","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/humrep\/den372","article-title":"Hyperandrogenism after transfer of topical testosterone gel: case report and review of published and unpublished studies","volume":"24","author":"de Ronde","year":"2009","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"2","key":"key\n\t\t\t\t20180406135425_B36","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/andr.307","article-title":"Designer steroids - over-the-counter supplements and their androgenic component: review of an increasing problem","volume":"3","author":"Rahnema","year":"2015","journal-title":"Andrology"},{"issue":"6","key":"key\n\t\t\t\t20180406135425_B37","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1093\/humrep\/17.6.1459","article-title":"Luteal phase progesterone excretion in ovulatory women with polycystic ovaries","volume":"17","author":"Joseph-Horne","year":"2002","journal-title":"Hum Reprod"},{"issue":"4","key":"key\n\t\t\t\t20180406135425_B38","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1210\/jc.2007-2437","article-title":"Evaluation and treatment of hirsutism in premenopausal women: an endocrine society clinical practice guideline","volume":"93","author":"Martin","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"key\n\t\t\t\t20180406135425_B39","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.fertnstert.2009.02.056","article-title":"High prevalence of polycystic ovary syndrome in women with mild hirsutism and no other significant clinical symptoms","volume":"94","author":"Di Fede","year":"2010","journal-title":"Fertil Steril"},{"issue":"12","key":"key\n\t\t\t\t20180406135425_B40","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1210\/jc.2013-2350","article-title":"Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline","volume":"98","author":"Legro","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"key\n\t\t\t\t20180406135425_B41","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ecl.2005.04.005","article-title":"Polycystic ovary syndrome in adolescence","volume":"34","author":"Buggs","year":"2005","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"6","key":"key\n\t\t\t\t20180406135425_B42","first-page":"1389","article-title":"ACOG Practice Bulletin. Clinical Management Guidelines for Obstetrician-Gynecologists: number 41, December 2002","volume":"100","author":"American College of Obstetricians and Gynecologists","year":"2002","journal-title":"Obstet Gynecol"},{"issue":"2","key":"key\n\t\t\t\t20180406135425_B43","doi-asserted-by":"crossref","first-page":"120","DOI":"10.4158\/EP.7.2.120","article-title":"American Association of Clinical Endocrinologists medical guidelines for the clinical practice for the diagnosis and treatment of hyperandrogenic disorders","volume":"7","author":"Goodman","year":"2001","journal-title":"Endocr Pract"},{"issue":"10","key":"key\n\t\t\t\t20180406135425_B44","doi-asserted-by":"crossref","first-page":"4111","DOI":"10.1073\/pnas.1014934108","article-title":"Cortisone-reductase deficiency associated with heterozygous mutations in 11beta-hydroxysteroid dehydrogenase type 1","volume":"108","author":"Lawson","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"key\n\t\t\t\t20180406135425_B45","doi-asserted-by":"crossref","first-page":"837","DOI":"10.3109\/09513590.2010.521263","article-title":"Leydig cell tumour of the ovary localised with positron emission tomography\/computed tomography","volume":"27","author":"Prassopoulos","year":"2011","journal-title":"Gynecol Endocrinol"},{"issue":"5","key":"key\n\t\t\t\t20180406135425_B46","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1365-2265.1994.tb01820.x","article-title":"Androgen suppressive effect of GnRH agonist in ovarian hyperthecosis and virilizing tumours","volume":"41","author":"Pascale","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"key\n\t\t\t\t20180406135425_B47","doi-asserted-by":"crossref","first-page":"S241","DOI":"10.1016\/j.fertnstert.2006.08.042","article-title":"The evaluation and treatment of androgen excess","volume":"86","author":"Practice Committee of the American Society for Reproductive Medicine","year":"2006","journal-title":"Fertil Steril"},{"issue":"1","key":"key\n\t\t\t\t20180406135425_B48","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ando.2009.12.007","article-title":"Recommendations for investigation of hyperandrogenism","volume":"71","author":"Pugeat","year":"2010","journal-title":"Ann Endocrinol (Paris)"},{"key":"key\n\t\t\t\t20180406135425_B49","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007506.pub3","volume-title":"Lifestyle Changes in Women With Polycystic Ovary Syndrome: Cochrane Database of Systematic Reviews","author":"Moran","year":"2011"},{"issue":"11","key":"key\n\t\t\t\t20180406135425_B50","doi-asserted-by":"crossref","first-page":"4048","DOI":"10.1210\/jc.2015-2778","article-title":"Randomized controlled trial of preconception interventions in infertile women with polycystic ovary syndrome","volume":"100","author":"Legro","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"key\n\t\t\t\t20180406135425_B51","doi-asserted-by":"crossref","first-page":"23S","DOI":"10.1016\/S0010-7824(98)00079-1","article-title":"Uniqueness of oral contraceptive progestins","volume":"58","author":"Carr","year":"1998","journal-title":"Contraception"},{"issue":"1","key":"key\n\t\t\t\t20180406135425_B52","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1749-6632.1995.tb31386.x","article-title":"Drospirenone: a novel progestogen with antimineralocorticoid and antiandrogenic activity","volume":"761","author":"Muhn","year":"1995","journal-title":"Ann N Y Acad Sci"},{"issue":"10-13","key":"key\n\t\t\t\t20180406135425_B53","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.steroids.2003.08.008","article-title":"Conception and pharmacodynamic profile of drospirenone","volume":"68","author":"Elger","year":"2003","journal-title":"Steroids"},{"issue":"1","key":"key\n\t\t\t\t20180406135425_B54","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1080\/09637480601137066","article-title":"Comparison of two oral contraceptives containing either drospirenone or cyproterone acetate in the treatment of hirsutism","volume":"23","author":"Batukan","year":"2007","journal-title":"Gynecol Endocrinol"},{"issue":"6","key":"key\n\t\t\t\t20180406135425_B55","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0015-0282(99)00146-6","article-title":"Effect of age on the response of the hypothalamo-pituitary-ovarian axis to a combined oral contraceptive","volume":"71","author":"Fitzgerald","year":"1999","journal-title":"Fertil Steril"},{"issue":"4","key":"key\n\t\t\t\t20180406135425_B56","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1210\/jcem-30-4-449","article-title":"Effect of medroxyprogesterone acetate (Provera) on the metabolism and biological activity of testosterone","volume":"30","author":"Gordon","year":"1970","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"key\n\t\t\t\t20180406135425_B57","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1210\/jcem-35-3-444","article-title":"The effect of medroxyprogesterone acetate on androgen metabolism in the polycystic ovary syndrome","volume":"35","author":"Gordon","year":"1972","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20180406135425_B58","doi-asserted-by":"crossref","first-page":"f5298","DOI":"10.1136\/bmj.f5298","article-title":"Different combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysis","volume":"347","author":"Stegeman","year":"2013","journal-title":"BMJ"},{"issue":"7","key":"key\n\t\t\t\t20180406135425_B59","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/1471-0528.12210","article-title":"Drospirenone-containing oral contraceptive pills and the risk of venous and arterial thrombosis: a systematic review","volume":"120","author":"Wu","year":"2013","journal-title":"BJOG"},{"issue":"4","key":"key\n\t\t\t\t20180406135425_B60","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.contraception.2014.01.023","article-title":"Cardiovascular and general safety of a 24-day regimen of drospirenone-containing combined oral contraceptives: final results from the International Active Surveillance Study of Women Taking Oral Contraceptives","volume":"89","author":"Dinger","year":"2014","journal-title":"Contraception"},{"key":"key\n\t\t\t\t20180406135425_B61","unstructured":"U.S. Food and Drug Administration . Updated external questions and answers \u2013 Ongoing safety review of birth control pills containing drospirenone and a possible increased risk of blood clots. 2012. Available at: http:\/\/www.fda.gov\/RegulatoryInformation\/Legislation\/FederalFoodDrugandCosmeticActFDCAct\/SignificantAmendmentstotheFDCAct\/ucm148011.htm. Accessed 20 January 2016."},{"issue":"5","key":"key\n\t\t\t\t20180406135425_B62","doi-asserted-by":"crossref","first-page":"377.e1","DOI":"10.1016\/j.ajog.2012.08.007","article-title":"Is polycystic ovary syndrome another risk factor for venous thromboembolism? United States, 2003-2008","volume":"207","author":"Okoroh","year":"2012","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"key\n\t\t\t\t20180406135425_B63","doi-asserted-by":"crossref","first-page":"E115","DOI":"10.1503\/cmaj.120677","article-title":"Risk of venous thromboembolism in women with polycystic ovary syndrome: a population-based matched cohort analysis","volume":"185","author":"Bird","year":"2013","journal-title":"CMAJ"},{"key":"key\n\t\t\t\t20180406135425_B64","unstructured":"EMA . Benefits of Diane 35 and its generics outweigh risks in certain patient groups \u2013 PRAC recommendation endorsed by CMDh.2013. Available at: www.ema.europa.eu\/ema\/index.jsp?curl=pages\/news_and_events\/news\/2013\/05\/news_detail_001801.jsp&mid=WC0b01ac058004d5c1. Accessed 12 October 2016."},{"issue":"4","key":"key\n\t\t\t\t20180406135425_B65","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/13625180008500402","article-title":"The effects of age, body mass index, smoking and general health on the risk of venous thromboembolism in users of combined oral contraceptives","volume":"5","author":"Nightingale","year":"2000","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"1","key":"key\n\t\t\t\t20180406135425_B66","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.contraception.2004.02.010","article-title":"Venous thromboembolic disease in users of low-estrogen combined estrogen-progestin oral contraceptives","volume":"70","author":"Sidney","year":"2004","journal-title":"Contraception"},{"issue":"3","key":"key\n\t\t\t\t20180406135425_B67","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1055\/s-0037-1613379","article-title":"Obesity: risk of venous thrombosis and the interaction with coagulation factor levels and oral contraceptive use","volume":"89","author":"Abdollahi","year":"2003","journal-title":"Thromb Haemost"},{"issue":"3","key":"key\n\t\t\t\t20180406135425_B68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6503a1","article-title":"U.S. medical eligibility criteria for contraceptive use, 2016","volume":"65","author":"Curtis","year":"2016","journal-title":"MMWR Recomm Rep"},{"key":"key\n\t\t\t\t20180406135425_B69","first-page":"109","article-title":"Treatment of hirsutism in polycystic ovarian syndrome with Diane, 50 mcg ethinyl estradiol and 2 mg cyproterone acetate","volume-title":"Specialist","author":"Saeed","year":"1993"},{"issue":"5","key":"key\n\t\t\t\t20180406135425_B70","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S0015-0282(16)54291-5","article-title":"Long-term treatment of hirsutism: desogestrel compared with cyproterone acetate in oral contraceptives","volume":"55","author":"Porcile","year":"1991","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20180406135425_B71","doi-asserted-by":"crossref","unstructured":"Barrionuevo P , NabhanM, AltayarO, WangZ, ErwinPG, AsiN, MartinKA, MuradMH. Treatment options for hirsutism: a systematic review and network meta-analysis. J Clin Endocrinol Metab. 2018;103(4):1258\u20131264.","DOI":"10.1210\/jc.2017-02052"},{"issue":"1","key":"key\n\t\t\t\t20180406135425_B72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0010-7824(00)00196-7","article-title":"Comparison of the lipoprotein, carbohydrate, and hemostatic effects of phasic oral contraceptives containing desogestrel or levonorgestrel","volume":"63","author":"Knopp","year":"2001","journal-title":"Contraception"},{"issue":"may26 13","key":"key\n\t\t\t\t20180406135425_B73","doi-asserted-by":"crossref","first-page":"h2135","DOI":"10.1136\/bmj.h2135","article-title":"Use of combined oral contraceptives and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases","volume":"350","author":"Vinogradova","year":"2015","journal-title":"BMJ"},{"issue":"1","key":"key\n\t\t\t\t20180406135425_B74","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/humupd\/dmt038","article-title":"The effect of combined oral contraception on testosterone levels in healthy women: a systematic review and meta-analysis","volume":"20","author":"Zimmerman","year":"2014","journal-title":"Hum Reprod Update"},{"issue":"5","key":"key\n\t\t\t\t20180406135425_B75","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.contraception.2011.03.002","article-title":"A prospective randomized trial comparing low-dose ethinyl estradiol and drospirenone 24\/4 combined oral contraceptive vs. ethinyl estradiol and drospirenone 21\/7 combined oral contraceptive in the treatment of hirsutism","volume":"84","author":"Oner","year":"2011","journal-title":"Contraception"},{"issue":"6","key":"key\n\t\t\t\t20180406135425_B76","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1016\/j.ajog.2005.02.067","article-title":"Effect of oral versus transdermal steroidal contraceptives on androgenic markers","volume":"192","author":"White","year":"2005","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"key\n\t\t\t\t20180406135425_B77","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0015-0282(16)48373-1","article-title":"The effects of two doses of spironolactone on serum androgens and anagen hair in hirsute women","volume":"43","author":"Lobo","year":"1985","journal-title":"Fertil Steril"},{"issue":"8","key":"key\n\t\t\t\t20180406135425_B78","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1055\/s-0028-1103628","article-title":"Intersexualit\u00e4t m\u00e4nnlicher Feten und Hemmung androgenabh\u00e4ngiger Funktionen bei erwachsenen Tieren durch Testosteronblocker","volume":"92","author":"Neumann","year":"1967","journal-title":"Dtsch Med Wochenschr"},{"issue":"3","key":"key\n\t\t\t\t20180406135425_B79","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/j.1749-6632.1967.tb14686.x","article-title":"Induced genital anomalies","volume":"142","author":"Goldman","year":"1967","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"key\n\t\t\t\t20180406135425_B80","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/0022-4731(84)90081-5","article-title":"Androgen metabolism in hirsute patients treated with cyproterone acetate","volume":"20","author":"Mowszowicz","year":"1984","journal-title":"J Steroid Biochem"},{"key":"key\n\t\t\t\t20180406135425_B81","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001125","volume-title":"Cyproterone Acetate for Hirsutism: Cochrane Database of Systematic Reviews","author":"van der Spuy","year":"2003"},{"issue":"6","key":"key\n\t\t\t\t20180406135425_B82","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1345\/aph.1D461","article-title":"Relative safety and efficacy of finasteride for treatment of hirsutism","volume":"38","author":"Townsend","year":"2004","journal-title":"Ann Pharmacother"},{"issue":"1","key":"key\n\t\t\t\t20180406135425_B83","first-page":"19","article-title":"Finasteride for hirsutism: a dose finding study","volume":"19","author":"Al-Khawajah","year":"1998","journal-title":"Saudi Med J"},{"issue":"4","key":"key\n\t\t\t\t20180406135425_B84","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1530\/eje.0.1470467","article-title":"Comparison of high-dose finasteride (5 mg\/day) versus low-dose finasteride (2.5 mg\/day) in the treatment of hirsutism","volume":"147","author":"Bayram","year":"2002","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"key\n\t\t\t\t20180406135425_B85","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1210\/jc.2007-2430","article-title":"Clinical review: antiandrogens for the treatment of hirsutism: a systematic review and metaanalyses of randomized controlled trials","volume":"93","author":"Swiglo","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"key\n\t\t\t\t20180406135425_B86","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0303-7207(86)90132-2","article-title":"Characteristics of interaction of the antiandrogen flutamide with the androgen receptor in various target tissues","volume":"44","author":"Simard","year":"1986","journal-title":"Mol Cell Endocrinol"},{"issue":"4","key":"key\n\t\t\t\t20180406135425_B87","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/S0015-0282(97)00266-5","article-title":"A comparison between two doses of flutamide (250 mg\/d and 500 mg\/d) in the treatment of hirsutism","volume":"68","author":"M\u00fcderris","year":"1997","journal-title":"Fertil Steril"},{"issue":"3","key":"key\n\t\t\t\t20180406135425_B88","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00404-008-0719-z","article-title":"The risk of hepatotoxicity during long-term and low-dose flutamide treatment in hirsutism","volume":"279","author":"Dikensoy","year":"2009","journal-title":"Arch Gynecol Obstet"},{"issue":"12","key":"key\n\t\t\t\t20180406135425_B89","doi-asserted-by":"crossref","first-page":"869","DOI":"10.3109\/09513590.2010.487589","article-title":"Low-dose pioglitazone, flutamide, metformin plus an estro-progestagen for non-obese young women with polycystic ovary syndrome: increasing efficacy and persistent safety over 30 months","volume":"26","author":"Ib\u00e1\u00f1ez","year":"2010","journal-title":"Gynecol Endocrinol"},{"issue":"1","key":"key\n\t\t\t\t20180406135425_B90","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3109\/09513590009167658","article-title":"Treatment of hirsutism with lowest-dose flutamide (62.5 mg\/day)","volume":"14","author":"M\u00fcderris","year":"2000","journal-title":"Gynecol Endocrinol"},{"issue":"1","key":"key\n\t\t\t\t20180406135425_B91","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1530\/EJE-10-0100","article-title":"Retrospective observational study on the effects and tolerability of flutamide in a large population of patients with various kinds of hirsutism over a 15-year period","volume":"163","author":"Paradisi","year":"2010","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"key\n\t\t\t\t20180406135425_B92","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.7326\/0003-4819-119-11-199312010-00020","article-title":"Hepatotoxicity complicating flutamide treatment of hirsutism","volume":"119","author":"Wallace","year":"1993","journal-title":"Ann Intern Med"},{"issue":"9157","key":"key\n\t\t\t\t20180406135425_B93","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(99)00564-4","article-title":"Fulminant liver failure associated with flutamide therapy for hirsutism","volume":"353","author":"Andrade","year":"1999","journal-title":"Lancet"},{"issue":"9517","key":"key\n\t\t\t\t20180406135425_B94","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/S0140-6736(06)68498-5","article-title":"Fatal liver complications with flutamide","volume":"367","author":"Osculati","year":"2006","journal-title":"Lancet"},{"issue":"9","key":"key\n\t\t\t\t20180406135425_B95","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.1210\/jc.2006-2798","article-title":"Long-term efficacy and tolerability of flutamide combined with oral contraception in moderate to severe hirsutism: a 12-month, double-blind, parallel clinical trial","volume":"92","author":"Calaf","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"key\n\t\t\t\t20180406135425_B96","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1210\/jcem.87.6.8568","article-title":"Additive effects of insulin-sensitizing and anti-androgen treatment in young, nonobese women with hyperinsulinism, hyperandrogenism, dyslipidemia, and anovulation","volume":"87","author":"Ib\u00e1\u00f1ez","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"key\n\t\t\t\t20180406135425_B97","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.fertnstert.2012.06.018","article-title":"Hepatotoxicity with low- and ultralow-dose flutamide: a surveillance study on 203 hyperandrogenic young females","volume":"98","author":"Bruni","year":"2012","journal-title":"Fertil Steril"},{"issue":"1","key":"key\n\t\t\t\t20180406135425_B98","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S1665-2681(19)31595-9","article-title":"Acute and fulminant hepatitis induced by flutamide: case series report and review of the literature","volume":"10","author":"Brahm","year":"2011","journal-title":"Ann Hepatol"},{"issue":"6","key":"key\n\t\t\t\t20180406135425_B99","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/BF03350769","article-title":"Comparison of cyproterone acetate plus ethinyl estradiol and finasteride in the treatment of hirsutism","volume":"21","author":"\u015eahin","year":"1998","journal-title":"J Endocrinol Invest"},{"issue":"6","key":"key\n\t\t\t\t20180406135425_B100","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0015-0282(98)00061-2","article-title":"The addition of dexamethasone to antiandrogen therapy for hirsutism prolongs the duration of remission","volume":"69","author":"Carmina","year":"1998","journal-title":"Fertil Steril"},{"issue":"5 Pt 1","key":"key\n\t\t\t\t20180406135425_B101","first-page":"845","article-title":"Peripheral androgen blockade versus glandular androgen suppression in the treatment of hirsutism","volume":"78","author":"Carmina","year":"1991","journal-title":"Obstet Gynecol"},{"issue":"9","key":"key\n\t\t\t\t20180406135425_B102","doi-asserted-by":"crossref","first-page":"4133","DOI":"10.1210\/jc.2009-2631","article-title":"Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline","volume":"95","author":"Speiser","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"key\n\t\t\t\t20180406135425_B103","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/BF01660957","article-title":"Therapie des Hirsutismus bei Frauen mit adrenalen Enzymdefekten der Steroidhormonbiosynthese: Vergleich von Dexamethason mit Cyproteronacetat","volume":"68","author":"Frank-Raue","year":"1990","journal-title":"Klin Wochenschr"},{"issue":"3","key":"key\n\t\t\t\t20180406135425_B104","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1210\/jcem-70-3-642","article-title":"Cyproterone acetate versus hydrocortisone treatment in late-onset adrenal hyperplasia","volume":"70","author":"Spritzer","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"key\n\t\t\t\t20180406135425_B105","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1210\/jc.2007-2429","article-title":"Clinical review: insulin sensitizers for the treatment of hirsutism: a systematic review and metaanalyses of randomized controlled trials","volume":"93","author":"Cosma","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20180406135425_B106","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD010334.pub2","volume-title":"Interventions for Hirsutism (Excluding Laser and Photoepilation Therapy Alone): Cochrane Database of Systematic Reviews","author":"van Zuuren","year":"2015"},{"issue":"4","key":"key\n\t\t\t\t20180406135425_B107","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1210\/jcem-70-4-1096","article-title":"Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism","volume":"70","author":"Rittmaster","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"key\n\t\t\t\t20180406135425_B108","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1210\/jcem-56-5-897","article-title":"Steroid secretion in polycystic ovarian disease after ovarian suppression by a long-acting gonadotropin-releasing hormone agonist","volume":"56","author":"Chang","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"key\n\t\t\t\t20180406135425_B109","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1210\/jcem-63-4-854","article-title":"Treatment of hirsutism with a gonadotropin-releasing hormone agonist (nafarelin)","volume":"63","author":"Andreyko","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"key\n\t\t\t\t20180406135425_B110","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1210\/jcem-65-4-773","article-title":"Clinical and hormonal effects of chronic gonadotropin-releasing hormone agonist treatment in polycystic ovarian disease","volume":"65","author":"Steingold","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"key\n\t\t\t\t20180406135425_B111","first-page":"3412","article-title":"Comparison of a gonadotropin-releasing hormone agonist and a low dose oral contraceptive given alone or together in the treatment of hirsutism","volume":"80","author":"Heiner","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"key\n\t\t\t\t20180406135425_B112","first-page":"1169","article-title":"Oral contraceptive pills, gonadotropin-releasing hormone agonists, or use in combination for treatment of hirsutism: a clinical research center study","volume":"80","author":"Carr","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"key\n\t\t\t\t20180406135425_B113","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0020-7292(93)90629-B","article-title":"Treatment of polycystic ovarian disease during adolescence with ethinylestradiol\/cyproterone acetate versus a D-Tr-6-LHRH analog","volume":"42","author":"Creatsas","year":"1993","journal-title":"Int J Gynaecol Obstet"},{"issue":"12","key":"key\n\t\t\t\t20180406135425_B114","first-page":"3406","article-title":"Leuprolide and estrogen versus oral contraceptive pills for the treatment of hirsutism: a prospective randomized study","volume":"80","author":"Azziz","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"key\n\t\t\t\t20180406135425_B115","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/humrep\/12.4.663","article-title":"Gonadotrophin-releasing hormone agonist therapy for hirsutism is as effective as high dose cyproterone acetate but results in a longer remission","volume":"12","author":"Carmina","year":"1997","journal-title":"Hum Reprod"},{"issue":"6","key":"key\n\t\t\t\t20180406135425_B116","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/S0015-0282(16)57593-1","article-title":"Depot leuprolide acetate versus danazol for treatment of pelvic endometriosis: changes in vertebral bone mass and serum estradiol and calcitonin","volume":"63","author":"Dawood","year":"1995","journal-title":"Fertil Steril"},{"issue":"1","key":"key\n\t\t\t\t20180406135425_B117","first-page":"126","article-title":"Physiological estrogen replacement may enhance the effectiveness of the gonadotropin-releasing hormone agonist in the treatment of hirsutism","volume":"78","author":"Carmina","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"key\n\t\t\t\t20180406135425_B118","first-page":"447","article-title":"Estrogen replacement does not potentiate gonadotropin-releasing hormone agonist-induced androgen suppression in treatment of hirsutism","volume":"79","author":"Tiitinen","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"key\n\t\t\t\t20180406135425_B119","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1159\/000248995","article-title":"Lack of effect of a spironolactone-containing cream on hair growth in hirsute women","volume":"174","author":"Gomez","year":"1987","journal-title":"Dermatologica"},{"issue":"1","key":"key\n\t\t\t\t20180406135425_B120","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4158\/EP.7.1.5","article-title":"Finasteride cream in hirsutism","volume":"7","author":"Lucas","year":"2001","journal-title":"Endocr Pract"},{"key":"key\n\t\t\t\t20180406135425_B121","unstructured":"Iraji F. Topical finasteride in hirsutism: a double blind randomized clinical trial on adult women. 2005. Available at: jrms.mui.ac.ir\/index.php\/jrms\/article\/view\/53. Accessed 20 November 2017."},{"issue":"4","key":"key\n\t\t\t\t20180406135425_B122","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/0190-9622(95)91290-8","article-title":"Electrolysis: observations from 13 years and 140,000 hours of experience","volume":"33","author":"Richards","year":"1995","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"key\n\t\t\t\t20180406135425_B123","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/j.1346-8138.1995.tb03912.x","article-title":"A comparative study of axillar hair removal in women: plucking versus the blend method","volume":"22","author":"Urushibata","year":"1995","journal-title":"J Dermatol"},{"issue":"2","key":"key\n\t\t\t\t20180406135425_B124","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1524-4725.1994.tb00129.x","article-title":"A double-blind placebo controlled study of a 5% lidocaine\/prilocaine cream (EMLA) for topical anesthesia during thermolysis","volume":"20","author":"Wagner","year":"1994","journal-title":"J Dermatol Surg Oncol"},{"issue":"6","key":"key\n\t\t\t\t20180406135425_B125","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0190-9622(96)90111-5","article-title":"Damage to hair follicles by normal-mode ruby laser pulses","volume":"35","author":"Grossman","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"key\n\t\t\t\t20180406135425_B126","unstructured":"ASAPS . Cosmetic Surgery National Data Bank. 2015. Available at: www.surgery.org\/media\/statistics. Accessed 12 October 2016."},{"issue":"4596","key":"key\n\t\t\t\t20180406135425_B127","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1126\/science.6836297","article-title":"Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation","volume":"220","author":"Anderson","year":"1983","journal-title":"Science"},{"issue":"5","key":"key\n\t\t\t\t20180406135425_B128","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/lsm.1136","article-title":"Extended theory of selective photothermolysis","volume":"29","author":"Altshuler","year":"2001","journal-title":"Lasers Surg Med"},{"issue":"2","key":"key\n\t\t\t\t20180406135425_B129","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3109\/09546634.2012.715239","article-title":"A comparative study of hair removal at an NHS hospital: luminette intense pulsed light versus electrolysis","volume":"25","author":"Harris","year":"2014","journal-title":"J Dermatolog Treat"},{"issue":"1","key":"key\n\t\t\t\t20180406135425_B130","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1046\/j.1524-4725.2000.99104.x","article-title":"Comparison of alexandrite laser and electrolysis for hair removal","volume":"26","author":"G\u00f6rg\u00fc","year":"2000","journal-title":"Dermatol Surg"},{"issue":"1","key":"key\n\t\t\t\t20180406135425_B131","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s10103-007-0515-1","article-title":"Meta-analysis of hair removal laser trials","volume":"24","author":"Sadighha","year":"2009","journal-title":"Lasers Med Sci"},{"key":"key\n\t\t\t\t20180406135425_B132","doi-asserted-by":"crossref","unstructured":"Haedersdal M , G\u00f8tzschePC. Laser and photoepilation for unwanted hair growth. Cochrane Database Syst Rev. 2006;(4):CD004684.","DOI":"10.1002\/14651858.CD004684.pub2"},{"issue":"5","key":"key\n\t\t\t\t20180406135425_B133","first-page":"573","article-title":"The role of number of treatments in laser-assisted hair removal using a 755-nm alexandrite laser","volume":"4","author":"Bouzari","year":"2005","journal-title":"J Drugs Dermatol"},{"issue":"1","key":"key\n\t\t\t\t20180406135425_B134","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/00006534-200207000-00043","article-title":"The long-term results of ruby laser depilation in a consecutive series of 346 patients","volume":"110","author":"Chana","year":"2002","journal-title":"Plast Reconstr Surg"},{"issue":"2","key":"key\n\t\t\t\t20180406135425_B135","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/14764170902984903","article-title":"Alexandrite laser hair removal results in 2359 patients: a Turkish experience","volume":"11","author":"Kutlubay","year":"2009","journal-title":"J Cosmet Laser Ther"},{"issue":"5","key":"key\n\t\t\t\t20180406135425_B136","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1111\/j.1365-2133.2010.10004.x","article-title":"Hair removal in hirsute women with normal testosterone levels: a randomized controlled trial of long-pulsed diode laser vs. intense pulsed light","volume":"163","author":"Haak","year":"2010","journal-title":"Br J Dermatol"},{"issue":"11","key":"key\n\t\t\t\t20180406135425_B137","first-page":"1255","article-title":"Comparison between sequentional treatment with diode and alexandrite lasers versus alexandrite laser alone in the treatment of hirsutism","volume":"10","author":"Nilforoushzadeh","year":"2011","journal-title":"J Drugs Dermatol"},{"issue":"10","key":"key\n\t\t\t\t20180406135425_B138","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/lsm.20584","article-title":"A randomised, split-face comparison of facial hair removal with the alexandrite laser and intense pulsed light system","volume":"39","author":"McGill","year":"2007","journal-title":"Lasers Surg Med"},{"issue":"5","key":"key\n\t\t\t\t20180406135425_B139","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1468-3083.2011.04353.x","article-title":"A systematic review of light-based home-use devices for hair removal and considerations on human safety","volume":"26","author":"Thaysen-Petersen","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"key\n\t\t\t\t20180406135425_B140","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s40257-014-0078-4","article-title":"Hirsutism: an evidence-based treatment update","volume":"15","author":"Somani","year":"2014","journal-title":"Am J Clin Dermatol"},{"issue":"2 Pt 1","key":"key\n\t\t\t\t20180406135425_B141","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0190-9622(99)70043-5","article-title":"Laser-assisted hair removal: side effects of Q-switched Nd:YAG, long-pulsed ruby, and alexandrite lasers","volume":"41","author":"Nanni","year":"1999","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"key\n\t\t\t\t20180406135425_B142","first-page":"920","article-title":"Laser hair removal: long-term results with a 755 nm alexandrite laser","volume":"27","author":"Eremia","year":"2001","journal-title":"Dermatol Surg"},{"issue":"6","key":"key\n\t\t\t\t20180406135425_B143","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1080\/09546630802132627","article-title":"Burning, paradoxical hypertrichosis, leukotrichia and folliculitis are four major complications of intense pulsed light hair removal therapy","volume":"19","author":"Radmanesh","year":"2008","journal-title":"J Dermatolog Treat"},{"issue":"5","key":"key\n\t\t\t\t20180406135425_B144","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s10103-011-0922-1","article-title":"Long-pulsed Nd:YAG laser-assisted hair removal in Fitzpatrick skin types IV-VI","volume":"26","author":"Rao","year":"2011","journal-title":"Lasers Med Sci"},{"issue":"2","key":"key\n\t\t\t\t20180406135425_B145","first-page":"191","article-title":"Patient satisfaction and complications following laser hair removal in ethnic skin","volume":"11","author":"Vachiramon","year":"2012","journal-title":"J Drugs Dermatol"},{"issue":"2","key":"key\n\t\t\t\t20180406135425_B146","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1001\/jamadermatol.2013.1384","article-title":"Common causes of injury and legal action in laser surgery","volume":"149","author":"Jalian","year":"2013","journal-title":"JAMA Dermatol"},{"issue":"3","key":"key\n\t\t\t\t20180406135425_B147","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1524-4725.2009.01433.x","article-title":"Paradoxical hypertrichosis after laser therapy: a review","volume":"36","author":"Desai","year":"2010","journal-title":"Dermatol Surg"},{"issue":"1","key":"key\n\t\t\t\t20180406135425_B148","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jaad.2004.06.054","article-title":"Paradoxical hypertrichosis after laser epilation","volume":"53","author":"Alajlan","year":"2005","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"key\n\t\t\t\t20180406135425_B149","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/lsm.20485","article-title":"Hair stimulation following laser and intense pulsed light photo-epilation: review of 543 cases and ways to manage it","volume":"39","author":"Willey","year":"2007","journal-title":"Lasers Surg Med"},{"issue":"1","key":"key\n\t\t\t\t20180406135425_B150","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jaad.2005.09.034","article-title":"Hair induction after laser-assisted hair removal and its treatment","volume":"54","author":"Kontoes","year":"2006","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"key\n\t\t\t\t20180406135425_B151","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1038\/eye.2008.436","article-title":"Ocular complications of laser-assisted eyebrow epilation","volume":"23","author":"Shulman","year":"2009","journal-title":"Eye (Lond)"},{"issue":"7","key":"key\n\t\t\t\t20180406135425_B152","first-page":"1","article-title":"Vaniqa--eflornithine 13.9% cream","volume":"6","author":"Shapiro","year":"2001","journal-title":"Skin Therapy Lett"},{"issue":"4","key":"key\n\t\t\t\t20180406135425_B153","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1185\/030079901750176735","article-title":"Human dermal safety studies with eflornithine HCl 13.9% cream (Vaniqa), a novel treatment for excessive facial hair","volume":"16","author":"Hickman","year":"2001","journal-title":"Curr Med Res Opin"},{"issue":"2","key":"key\n\t\t\t\t20180406135425_B154","first-page":"38","article-title":"[Eflornithine for hair removal. Topical application for hirsutism]","volume":"24","author":"Hennemann","year":"2001","journal-title":"Med Monatsschr Pharm"},{"issue":"9","key":"key\n\t\t\t\t20180406135425_B155","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1177\/00912700122010951","article-title":"Percutaneous absorption and pharmacokinetics of eflornithine HCl 13.9% cream in women with unwanted facial hair","volume":"41","author":"Malhotra","year":"2001","journal-title":"J Clin Pharmacol"},{"issue":"1","key":"key\n\t\t\t\t20180406135425_B156","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1365-4632.2006.03079.x","article-title":"Randomized, double-blind clinical evaluation of the efficacy and safety of topical eflornithine HCl 13.9% cream in the treatment of women with facial hair","volume":"46","author":"Wolf","year":"2007","journal-title":"Int J Dermatol"},{"issue":"10","key":"key\n\t\t\t\t20180406135425_B157","first-page":"1237","article-title":"Eflornithine cream combined with laser therapy in the management of unwanted facial hair growth in women: a randomized trial","volume":"32","author":"Smith","year":"2006","journal-title":"Dermatol Surg"},{"issue":"1","key":"key\n\t\t\t\t20180406135425_B158","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jaad.2006.09.025","article-title":"A randomized bilateral vehicle-controlled study of eflornithine cream combined with laser treatment versus laser treatment alone for facial hirsutism in women","volume":"57","author":"Hamzavi","year":"2007","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"key\n\t\t\t\t20180406135425_B159","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1172\/JCI105344","article-title":"Androstenedione production and interconversion rates measured in peripheral blood and studies on the possible site of its conversion to testosterone","volume":"45","author":"Horton","year":"1966","journal-title":"J Clin Invest"},{"issue":"2","key":"key\n\t\t\t\t20180406135425_B160","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1055\/s-2007-961807","article-title":"Sexual hormones in human skin","volume":"39","author":"Zouboulis","year":"2007","journal-title":"Horm Metab Res"},{"issue":"2","key":"key\n\t\t\t\t20180406135425_B161","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1677\/joe.1.05762","article-title":"Androgen generation in adipose tissue from women with simple obesity \u2013 a site-specific role for 17\u03b2-hydroxysteroid dehydrogenase type 5","volume":"183","author":"Quinkler","year":"2004","journal-title":"J Endocrinol"},{"key":"key\n\t\t\t\t20180406135425_B162","first-page":"24","volume-title":"Androgenization in Women","author":"Rosenfeld","year":"1983"},{"issue":"6","key":"key\n\t\t\t\t20180406135425_B163","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1210\/jc.2005-2847","article-title":"Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline","volume":"91","author":"Bhasin","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"key\n\t\t\t\t20180406135425_B164","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.1210\/jc.2006-1121","article-title":"Androgen therapy in women: an Endocrine Society Clinical Practice guideline","volume":"91","author":"Wierman","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"key\n\t\t\t\t20180406135425_B165","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1210\/jc.2006-1864","article-title":"Position statement: utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement","volume":"92","author":"Rosner","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"key\n\t\t\t\t20180406135425_B166","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1210\/er.2017-00025","article-title":"A reappraisal of testosterone\u2019s binding in circulation: physiological and clinical implications","volume":"38","author":"Goldman","year":"2017","journal-title":"Endocr Rev"},{"issue":"6","key":"key\n\t\t\t\t20180406135425_B167","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1210\/jcem-32-6-717","article-title":"Plasma testosterone binding globulin and indexes of the concentration of unbound plasma androgens in normal and hirsute subjects","volume":"32","author":"Rosenfield","year":"1971","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"key\n\t\t\t\t20180406135425_B168","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1210\/jcem-49-5-730","article-title":"Testosterone binding and free plasma androgen concentrations under physiological conditons: chararacterization by flow dialysis technique","volume":"49","author":"Moll","year":"1979","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"key\n\t\t\t\t20180406135425_B169","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.mce.2009.09.020","article-title":"Sex hormone-binding globulin gene expression in the liver: drugs and the metabolic syndrome","volume":"316","author":"Pugeat","year":"2010","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"key\n\t\t\t\t20180406135425_B170","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1210\/jcem-72-1-83","article-title":"A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome","volume":"72","author":"Nestler","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"key\n\t\t\t\t20180406135425_B171","doi-asserted-by":"crossref","first-page":"372","DOI":"10.2337\/db11-0727","article-title":"Potential role of tumor necrosis factor-\u03b1 in downregulating sex hormone-binding globulin","volume":"61","author":"Sim\u00f3","year":"2012","journal-title":"Diabetes"},{"issue":"7","key":"key\n\t\t\t\t20180406135425_B172","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1172\/JCI0214060","article-title":"Human sex hormone-binding globulin variants associated with hyperandrogenism and ovarian dysfunction","volume":"109","author":"Hogeveen","year":"2002","journal-title":"J Clin Invest"},{"issue":"10","key":"key\n\t\t\t\t20180406135425_B173","doi-asserted-by":"crossref","first-page":"4542","DOI":"10.1210\/jc.2010-1314","article-title":"Toward excellence in testosterone testing: a consensus statement","volume":"95","author":"Rosner","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"key\n\t\t\t\t20180406135425_B174","doi-asserted-by":"crossref","first-page":"5305","DOI":"10.1210\/jc.2010-1123","article-title":"Total testosterone assays in women with polycystic ovary syndrome: precision and correlation with hirsutism","volume":"95","author":"Legro","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"key\n\t\t\t\t20180406135425_B175","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1093\/humrep\/der291","article-title":"Determination of the source of androgen excess in functionally atypical polycystic ovary syndrome by a short dexamethasone androgen-suppression test and a low-dose ACTH test","volume":"26","author":"Rosenfield","year":"2011","journal-title":"Hum Reprod"},{"issue":"1","key":"key\n\t\t\t\t20180406135425_B176","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/md.0b013e3181946a2c","article-title":"Androgen dependence of hirsutism, acne, and alopecia in women: retrospective analysis of 228 patients investigated for hyperandrogenism","volume":"88","author":"Karrer-Voegeli","year":"2009","journal-title":"Medicine (Baltimore)"},{"key":"key\n\t\t\t\t20180406135425_B177","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.steroids.2014.04.013","article-title":"A critical evaluation of salivary testosterone as a method for the assessment of serum testosterone","volume":"86","author":"Fiers","year":"2014","journal-title":"Steroids"},{"issue":"9","key":"key\n\t\t\t\t20180406135425_B178","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1093\/clinchem\/38.9.1819","article-title":"Low ratio of androstenedione to testosterone in plasma and saliva of hirsute women","volume":"38","author":"Swinkels","year":"1992","journal-title":"Clin Chem"},{"issue":"5\u20136","key":"key\n\t\t\t\t20180406135425_B179","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.cca.2011.11.029","article-title":"Determination of salivary testosterone and androstendione by liquid chromatography-tandem mass spectrometry","volume":"413","author":"Turpeinen","year":"2012","journal-title":"Clin Chim Acta"},{"key":"key\n\t\t\t\t20180406135425_B180","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0039-128X(65)90120-0","article-title":"Direct peripheral conversion of dehydroepiandrosterone to testosterone glucuroniside","volume":"85","author":"Korenman","year":"1965","journal-title":"Steroids"},{"issue":"8","key":"key\n\t\t\t\t20180406135425_B181","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1210\/jcem-26-8-893","article-title":"Testosterone excretion and production rate in normal adults and in patients with congenital adrenal hyperplasia","volume":"26","author":"Camacho","year":"1966","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"key\n\t\t\t\t20180406135425_B182","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1210\/jcem.84.10.6079","article-title":"A critical evaluation of simple methods for the estimation of free testosterone in serum","volume":"84","author":"Vermeulen","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"key\n\t\t\t\t20180406135425_B183","first-page":"810","article-title":"Clinical review 56: nonclassic adrenal hyperplasia: current concepts","volume":"78","author":"Azziz","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"key\n\t\t\t\t20180406135425_B184","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1210\/jc.2016-3285","article-title":"11-Oxygenated C19 steroids are the predominant androgens in polycystic ovary syndrome","volume":"102","author":"O\u2019Reilly","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"key\n\t\t\t\t20180406135425_B185","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/MED.0000000000000334","article-title":"Clinical significance of 11-oxygenated androgens","volume":"24","author":"Turcu","year":"2017","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"key\n\t\t\t\t20180406135425_B186","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jsbmb.2015.11.005","article-title":"Development of a novel cell based androgen screening model","volume":"156","author":"Campana","year":"2016","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"4","key":"key\n\t\t\t\t20180406135425_B187","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/00006254-198604000-00017","article-title":"High frequency of nonclassical steroid 21-hydroxylase deficiency","volume":"41","author":"Speiser","year":"1986","journal-title":"Obstet Gynecol Surv"},{"issue":"4","key":"key\n\t\t\t\t20180406135425_B188","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1056\/NEJM198507253130404","article-title":"Late-onset adrenal hyperplasia in hirsutism","volume":"313","author":"Kuttenn","year":"1985","journal-title":"N Engl J Med"},{"issue":"2","key":"key\n\t\t\t\t20180406135425_B189","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1210\/jc.2007-2053","article-title":"A prospective study of the prevalence of nonclassical congenital adrenal hyperplasia among women presenting with hyperandrogenic symptoms and signs","volume":"93","author":"Escobar-Morreale","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"key\n\t\t\t\t20180406135425_B190","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1210\/jc.2008-1582","article-title":"Clinical and molecular characterization of a cohort of 161 unrelated women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency and 330 family members","volume":"94","author":"Bidet","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"key\n\t\t\t\t20180406135425_B191","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/cen.12935","article-title":"The diagnosis of nonclassic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, based on serum basal or post-ACTH stimulation 17-hydroxyprogesterone, can lead to false-positive diagnosis","volume":"84","author":"Ambroziak","year":"2016","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/103\/4\/1233\/24565791\/jc.2018-00241.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T22:29:27Z","timestamp":1603924167000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/103\/4\/1233\/4924418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,7]]},"references-count":191,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,3,7]]},"published-print":{"date-parts":[[2018,4,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2018-00241","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,4]]},"published":{"date-parts":[[2018,3,7]]}}}